148 related articles for article (PubMed ID: 26797960)
1. Yield of Urinalysis Screening in Pediatric Cancer Survivors.
Ramirez MD; Mertens AC; Esiashvili N; Meacham LR; Wasilewski-Masker K
Pediatr Blood Cancer; 2016 May; 63(5):893-900. PubMed ID: 26797960
[TBL] [Abstract][Full Text] [Related]
2. Yield of screening for long-term complications using the children's oncology group long-term follow-up guidelines.
Landier W; Armenian SH; Lee J; Thomas O; Wong FL; Francisco L; Herrera C; Kasper C; Wilson KD; Zomorodi M; Bhatia S
J Clin Oncol; 2012 Dec; 30(35):4401-8. PubMed ID: 23091100
[TBL] [Abstract][Full Text] [Related]
3. Prospective evaluation of routine admission urinalyses.
Hermansen MC; Blodgett FM
Am J Dis Child; 1981 Feb; 135(2):126-30. PubMed ID: 6781335
[TBL] [Abstract][Full Text] [Related]
4. Yield of screening echocardiograms during pediatric follow-up in survivors treated with anthracyclines and cardiotoxic radiation.
Spewak MB; Williamson RS; Mertens AC; Border WL; Meacham LR; Wasilewski-Masker KJ
Pediatr Blood Cancer; 2017 Jun; 64(6):. PubMed ID: 27966803
[TBL] [Abstract][Full Text] [Related]
5. Accuracy of dipstick urinalysis as a screening method for detection of glucose, protein, nitrites and blood.
Zamanzad B
East Mediterr Health J; 2009; 15(5):1323-8. PubMed ID: 20214148
[TBL] [Abstract][Full Text] [Related]
6. Severity of health conditions identified in a pediatric cancer survivor program.
Wasilewski-Masker K; Mertens AC; Patterson B; Meacham LR
Pediatr Blood Cancer; 2010 Jul; 54(7):976-82. PubMed ID: 20108334
[TBL] [Abstract][Full Text] [Related]
7. Problems in assessing screening experience in observational studies of screening efficacy: example of urinalysis screening for bladder cancer.
Friedman GD; Hiatt RA; Quesenberry CP; Selby JV; Weiss NS
J Med Screen; 1995; 2(4):219-23. PubMed ID: 8719152
[TBL] [Abstract][Full Text] [Related]
8. Echocardiographic surveillance for asymptomatic late-onset anthracycline cardiomyopathy in childhood cancer survivors.
Abosoudah I; Greenberg ML; Ness KK; Benson L; Nathan PC
Pediatr Blood Cancer; 2011 Sep; 57(3):467-72. PubMed ID: 21280201
[TBL] [Abstract][Full Text] [Related]
9. Long-term follow-up of pediatric cancer survivors: education, surveillance, and screening.
Landier W; Wallace WH; Hudson MM
Pediatr Blood Cancer; 2006 Feb; 46(2):149-58. PubMed ID: 16369924
[TBL] [Abstract][Full Text] [Related]
10. Induction of transient proteinuria, hematuria, and glucosuria by ethanol consumption in Japanese alcoholics.
Ito S; Ueno M; Izumi T; Arakawa M
Nephron; 1999; 82(3):246-53. PubMed ID: 10395997
[TBL] [Abstract][Full Text] [Related]
11. Urinalysis. When--and when not--to order.
Misdraji J; Nguyen PL
Postgrad Med; 1996 Jul; 100(1):173-6, 181-2, 185-8 passim. PubMed ID: 8668615
[TBL] [Abstract][Full Text] [Related]
12. Development of risk-based guidelines for pediatric cancer survivors: the Children's Oncology Group Long-Term Follow-Up Guidelines from the Children's Oncology Group Late Effects Committee and Nursing Discipline.
Landier W; Bhatia S; Eshelman DA; Forte KJ; Sweeney T; Hester AL; Darling J; Armstrong FD; Blatt J; Constine LS; Freeman CR; Friedman DL; Green DM; Marina N; Meadows AT; Neglia JP; Oeffinger KC; Robison LL; Ruccione KS; Sklar CA; Hudson MM
J Clin Oncol; 2004 Dec; 22(24):4979-90. PubMed ID: 15576413
[TBL] [Abstract][Full Text] [Related]
13. Emergency department visual urinalysis versus laboratory urinalysis.
Worrall JC
CJEM; 2009 Nov; 11(6):540-3. PubMed ID: 19922714
[TBL] [Abstract][Full Text] [Related]
14. Analysis of Risk Factors for Abnormal Pulmonary Function in Pediatric Cancer Survivors.
Record E; Williamson R; Wasilewski-Masker K; Mertens AC; Meacham LR; Popler J
Pediatr Blood Cancer; 2016 Jul; 63(7):1264-71. PubMed ID: 27002916
[TBL] [Abstract][Full Text] [Related]
15. Renal dysfunctions secondary to ifosfamide treatment in children.
Tokuc G; Yalçiner A; Kebudi R; Dogan S; Görgün O; Ayan I
J Exp Clin Cancer Res; 1997 Jun; 16(2):227-30. PubMed ID: 9261752
[TBL] [Abstract][Full Text] [Related]
16. New health conditions identified at a regional childhood cancer survivor clinic visit.
Staba Hogan MJ; Ma X; Kadan-Lottick NS
Pediatr Blood Cancer; 2013 Apr; 60(4):682-7. PubMed ID: 23023769
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive Echocardiographic Detection of Treatment-Related Cardiac Dysfunction in Adult Survivors of Childhood Cancer: Results From the St. Jude Lifetime Cohort Study.
Armstrong GT; Joshi VM; Ness KK; Marwick TH; Zhang N; Srivastava D; Griffin BP; Grimm RA; Thomas J; Phelan D; Collier P; Krull KR; Mulrooney DA; Green DM; Hudson MM; Robison LL; Plana JC
J Am Coll Cardiol; 2015 Jun; 65(23):2511-22. PubMed ID: 26065990
[TBL] [Abstract][Full Text] [Related]
18. Institutional adherence to cardiovascular risk factor screening guidelines for young survivors of acute lymphoblastic leukemia.
Lin MH; Wood JR; Mittelman SD; Freyer DR
J Pediatr Hematol Oncol; 2015 May; 37(4):e253-7. PubMed ID: 25757021
[TBL] [Abstract][Full Text] [Related]
19. Specialized survivor clinic attendance increases adherence to cardiomyopathy screening guidelines in adult survivors of childhood cancer.
Marr KC; Agha M; Sutradhar R; Pole JD; Hodgson D; Guttmann A; Greenberg M; Nathan PC
J Cancer Surviv; 2017 Oct; 11(5):614-623. PubMed ID: 28785871
[TBL] [Abstract][Full Text] [Related]
20. Endocrine health problems detected in 519 patients evaluated in a pediatric cancer survivor program.
Patterson BC; Wasilewski-Masker K; Ryerson AB; Mertens A; Meacham L
J Clin Endocrinol Metab; 2012 Mar; 97(3):810-8. PubMed ID: 22188743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
